Table of Content

1. Table of Contents
1.1 List of Tables
1.2 List of Figures


2. Executive Summary
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Pulmonary Arterial Hypertension Market- Key Findings, 2020


3. Strategic Imperatives on Global Pulmonary Arterial Hypertension Market
3.1 COVID-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Pulmonary Arterial Hypertension Companies


4. Global Pulmonary Arterial Hypertension Market Value Outlook to 2026 Outlook by Drug Class
4.1 Prostacyclin and Prostacyclin Analogs
4.2 Soluble Guanylate Cyclase (Sgc) Stimulators
4.3 Endothelin Receptor Antagonists
4.4 Phosphodiesterase
4.5 Others


5 Asia Pacific Pulmonary Arterial Hypertension Market Value Outlook to 2026
5.1 Leading Pulmonary Arterial Hypertension Types contributing to Asia Pacific market
5.2 Top Applications contributing to Asia Pacific Pulmonary Arterial Hypertension
5.3 Top countries contributing to Asia Pacific Pulmonary Arterial Hypertension


6 Europe Pulmonary Arterial Hypertension Market Value Outlook to 2026
6.1 Leading Pulmonary Arterial Hypertension Types contributing to Europe market
6.2 Top Applications contributing to Europe Pulmonary Arterial Hypertension
6.3 Top countries contributing to Europe Pulmonary Arterial Hypertension


7 North America Pulmonary Arterial Hypertension Market Value Outlook to 2026
7.1 Leading Pulmonary Arterial Hypertension Types contributing to North America market
7.2 Top Applications contributing to North America Pulmonary Arterial Hypertension
7.3 Top countries contributing to North America Pulmonary Arterial Hypertension


8 South and Central America Pulmonary Arterial Hypertension Market Value Outlook to 2026
8.1 Leading Pulmonary Arterial Hypertension Types contributing to South and Central America market
8.2 Top Applications contributing to South and Central America Pulmonary Arterial Hypertension
8.3 Top countries contributing to South and Central America Pulmonary Arterial Hypertension


9 Middle East Africa Pulmonary Arterial Hypertension Market Value Outlook to 2026
9.1 Leading Pulmonary Arterial Hypertension Types contributing to Middle East Africa market
9.2 Top Applications contributing to Middle East Africa Pulmonary Arterial Hypertension
9.3 Top countries contributing to Middle East Africa Pulmonary Arterial Hypertension


10 Business Profiles of Leading Companies
10.1 Business Description, SWOT and Financial Analysis of Companies in Pulmonary Arterial Hypertension market
10.2 Actelion Pharmaceuticals
10.3 Arena Pharmaceuticals
10.4 Bayer HealthCare
10.5 Dong-A ST Co
10.6 Gilead Sciences
10.7 GlaxoSmithKline Plc
10.8 Merck Sharp & Dohme Corp
10.9 Novartis International
10.10 Pfizer
10.11 United Therapeutics Corporation


11 Recent Industry Developments


12 Appendix
12.1 OGAnalysis Expertise
12.2 Sources and Methodology
12.3 Contacts